Hirano Satoshi, Tanaka Eiichi, Tsuchikawa Takahiro, Matsumoto Joe, Kawakami Hiroshi, Nakamura Toru, Kurashima Yo, Ebihara Yuma, Shichinohe Toshiaki
Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan.
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):533-40. doi: 10.1002/jhbp.76. Epub 2014 Jan 27.
Due to advances in endoscopic equipment and techniques, preoperative endoscopic biliary drainage (EBD) has been developed to serve as an alternative to percutaneous transhepatic biliary drainage (PTBD). This study sought to clarify the benefit of EBD in comparison to PTBD in patients who underwent radical resections of hilar cholangiocarcinoma. One hundred and forty-one patients underwent radical surgery for hilar cholangiocarcinoma between 2000 and 2008 were retrospectively divided into two groups based on the type of preoperative biliary drainage, PTBD (n = 67) or EBD (n = 74). We investigated if the different biliary drainage methods affected postoperative survival and mode of recurrence after median observation period of 82 months. The survival rate for patients who underwent EBD was significantly higher than those who had PTBD (P = 0.004). Multivariate analysis revealed that PTBD was one of the independent factors predictive of poor survival (hazard ratio: 2.075, P = 0.003). Patients with PTBD more frequently developed peritoneal seeding in comparison to those who underwent EBD (P = 0.0003). PTBD was the only independent factor predictive of peritoneal seeding. In conclusion, EBD might confer an improved prognosis over PTBD due to prevention of peritoneal seeding, and is recommended as the initial procedure for preoperative biliary drainage in patients with hilar cholangiocarcinoma.
由于内镜设备和技术的进步,术前内镜下胆道引流(EBD)已被开发出来作为经皮经肝胆道引流(PTBD)的替代方法。本研究旨在阐明在接受肝门部胆管癌根治性切除术的患者中,EBD与PTBD相比的益处。对2000年至2008年间接受肝门部胆管癌根治性手术的141例患者,根据术前胆道引流类型回顾性分为两组,即PTBD组(n = 67)和EBD组(n = 74)。在中位观察期82个月后,我们调查了不同的胆道引流方法是否会影响术后生存率和复发模式。接受EBD的患者生存率显著高于接受PTBD的患者(P = 0.004)。多因素分析显示,PTBD是预测生存不良的独立因素之一(风险比:2.075,P = 0.003)。与接受EBD的患者相比,PTBD患者更频繁地发生腹膜种植(P = 0.0003)。PTBD是预测腹膜种植的唯一独立因素。总之,EBD可能由于预防了腹膜种植而比PTBD具有更好的预后,因此推荐作为肝门部胆管癌患者术前胆道引流的初始方法。